Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: life extension

Most of us are now familiar with apps that track what’s known as our ‘digital biomarkers’. These include the steps, we’ve taken, our heart rate, and our weight. In recent years startups have appeared which can, in a relatively turnkey manner, track our ‘biomedical markers’, such as cholesterol levels, for instance. Few, however, are seeking to combine the two to get a 360-degree view of how our bodies are doing.

Into this gap steps Humanity Inc., which will seek to do exactly that. Founded by two seasoned entrepreneurs, Humanity will combine digital and biomedical biomarkers into a consumer app that will fully launch next year.

Today it announces it’s initial seed fundraise of $2.5m, in a round led by Boston fund One Way Ventures and the legendary and long-time HealthTech Angel investor Esther Dyson, among others.

Read more | >

Summary: Researchers identified a group of closely related genes that capture molecular links between Alzheimer’s and LATE, a common brain disorder that mimics Alzheimer’s symptoms.

Source: Brigham and Women’s Hospital

Alzheimer’s disease is one of the most common causes of dementia, and while most people might know someone who is affected by it, the genetic factors behind the disease are less known. A new study by investigators from Brigham and Women’s Hospital uncovered a group of closely related genes that may capture molecular links between Alzheimer’s disease and Limbic-predominant Age-related TDP-43 Encephalopathy, or LATE, a recently recognized common brain disorder that can mimic Alzheimer’s symptoms. LATE is often combined with Alzheimer’s disease to cause a more rapid cognitive decline. The study’s results are published in Neuron.

Read more | >

Scientists investigating Alzheimer’s treatments at the Salk Institute have uncovered some key mechanisms that enable an experimental drug to reverse memory loss in mouse models of the disease. The discovery not only bodes well for the possibility of clinical trials, but provides researchers with a new target to consider in the wider development of compounds to counter the degenerative effects of the condition.

The research centers on a drug called CMS121, which is a synthetic version of a chemical called fisetin that occurs naturally in fruits and vegetables. The Salk team’s previous studies concerning CMS121 have produced some very promising results, with one paper published last year describing how the drug influences age-related metabolic pathways in the brain, protecting against the type of degeneration associated with Alzheimer’s. This followed earlier studies demonstrating how fisetin can prevent memory loss in mice engineered to develop Alzheimer’s.

Work continues at Salk to understand how exactly fisetin and the synthetic variant CMS121 produces these anti-aging effects on the brain. In their latest study, the researchers again turned to mice engineered to develop Alzheimer’s, which were administered daily doses of CMS121 from the age of nine months. This is the equivalent to middle age in humans, with the mice already exhibiting learning and memory problems before the treatment began.

Read more | >

“Observations of metastasising cells revealed something intriguing—a high level of something called methylmalonic acid (MMA), a metabolic byproduct that appears to accumulate as we get older.”

“So how does MMA induce these changes in cancer cells? The key seems to be in a sort of reprogramming that “switches on” a gene called SOX4.

Prior research has shown SOX4 encourages cancer cells to become more aggressive and prone to metastasis.

To test whether it was indeed SOX4 that was altering the qualities of the cancer cells, the team blocked expression of the gene, and found that MMA no longer appeared to have the same effect.

Blocking SOX4 also stopped the process by which the cancer cells were able to resist two cancer treatments.”

As our bodies convert food into energy, they produce debris that accumulates as we age. New research shows that one of these metabolic throwaways plays a potentially deadly role in the development of cancer.

The finding adds to a body of knowledge about the ways in which the accelerates our chances of developing deadly cancers, but also offers potential avenues for blocking metastasising tumors.

The study, published Wednesday in the journal Nature, grew from work on metastasis, the process by which detach from an initial tumor and former new tumors elsewhere in the body.

Read more | >

Research is showing a strong link between handgrip strength, walking speed, and cognition, indicating how improved physical health could boost elderly minds.

Based at Barwon Health, in the heart of Geelong’s clinical precinct, researchers are working to identify the —such as changes in , muscle strength and physical performance—for developing sarcopenia (loss of muscle mass, strength and function with advancing age) across the lifespan.

This testing involves the Geelong Osteoporosis Study (GOS) which began in the early 1990s, gathering adult participants from the electoral roll in the Barwon Statistical Division. During recent follow-up testing, researchers also measured cognitive function through a computer-based program, in tandem with evaluations.

Read more | >

For decades, greater than 60% of the human genome was believed to be “junk DNA” that served little or no purpose in the course of human development. Recent research by Colorado State University is challenging this notion to show that junk DNA might be important after all.

A new study, published on June 5 in Aging Cell, found that a portion of noncoding genetic material, called repetitive element transcripts, might be an important biomarker of the aging process.

Tom LaRocca, an assistant professor in the Department of Health and Exercise Science and faculty member in the Columbine Heath Systems Center for Healthy Aging at CSU, led the study to investigate a growing body of evidence that repetitive elements—transposons and other sequences that occur in multiple copies in the —may become active over time as we age.

Read more | >

Aubrey interviewed by, um, alien scientists.

Our conversation covers the importance of non-academic institutions in science, strategies for combating for repair the damage of aging, and an exploration of how extending human lifespan will change the Earth. In Dr. de Gray’s perspective, age-related decline is a medical problem like any other that can be treated and cured by cutting edge technology. He’s devoted himself to this pursuit as a founder of the SENS Research Foundation, the Methuselah Foundation, and the medical startup AgeX.

Please subscribe to our channel so we can bring you more like this!!!

Support Dr. de Grey & DS when you buy his books:
Ending Aging: https://amzn.to/31Wyo4V
Advocate for An Indefinite Human Lifespan: https://amzn.to/3kPHJUP

SENS Foundation: https://www.sens.org
Aubrey de Grey: https://twitter.com/aubreydegrey

More readings from us:
https://demystifyingscience.com

Demystifying Science Mailing List: http://eepurl.com/gRUCZL

Let’s talk! @DemystifySci
Twitter: https://twitter.com/demystifysci
Instagram: https://www.instagram.com/demystifysci
Facebook: https://www.facebook.com/demystifysci
Podcast: https://anchor.fm/demystifying-science

Read more | >

NR and NMN are popular ways to try to boost levels of NAD+, but that approach hasn’t worked every time in human studies. One reason for that may involve CD38, which degrades both NR and NMN. With the goal of boosting NAD+ levels during aging, why does CD38 increase with age, and what can be done about it? All that and more in this video!

Read more | >

Every dog owner has their own reasons for getting a pet, whether it is companionship, protection, or simply to have a furry friend to walk with. Each different breed comes with perks and challenges, and owners must be prepared to accommodate each type of dog’s unique health requirements to maximize their lifespan, because the reality is that some dogs are genetically predisposed to live much longer than others.

In order to determine the shortest and longest living dog breeds in the world, 24/7 Tempo reviewed the study, “Methods and mortality results of a health survey of purebred dogs in the UK,” published in the Journal of Small Animal Practice. Breeds for which there was little data or low response rates on surveys sent to owners were not considered. Breeds that are not officially recognized by the American Kennel Club were also not considered. Breed popularity data, as well as height and weight data, comes from the AKC. The height refers to the height of the dog’s shoulder.

Numerous studies have determined that there is a significant link between the size of a dog and the length of its lifespan — larger dogs have noticeably shorter lifespans than smaller dogs, as they age at a faster rate. Yet size and lifespan do not correlate exactly, as certain types of dogs are especially prone to maladies like cancer or heart problems.

Read more | >